CAMELOT BIOCAPITAL

Our model is to partner with inventors, research centers, and academic institutions and leverage our industry relationships including scientific advisors, healthcare bankers, CROs, investors, and patent attorneys to rapidly move novel therapeutic compounds down the FDA pipeline in an attempt to deliver these treatments to patients in need... Camelot's pipeline includes therapeutics from inventors, research centers, and academic institutions around the world. Our expertise is in oncology, neurologic disease, and orphan disease advancements.